|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-1-26
|
|
pubmed:abstractText |
Our work was undertaken to determine the usefulness ofYKL-40 as a tumor marker in patients with ovarian cancer and women with BRCA 1 gene mutations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-2936
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
668-71
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20099501-Adipokines,
pubmed-meshheading:20099501-CA-125 Antigen,
pubmed-meshheading:20099501-Case-Control Studies,
pubmed-meshheading:20099501-Female,
pubmed-meshheading:20099501-Genes, BRCA1,
pubmed-meshheading:20099501-Glycoproteins,
pubmed-meshheading:20099501-Humans,
pubmed-meshheading:20099501-Lectins,
pubmed-meshheading:20099501-Mutation,
pubmed-meshheading:20099501-Ovarian Neoplasms,
pubmed-meshheading:20099501-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Serum YKL-40 levels in patients with ovarian cancer and women with BRCA1 gene mutation--comparison to CA 125 antigen.
|
|
pubmed:affiliation |
Department of Gynecological Surgery and Gynecological Oncology of Adults and Adolescents Pomeranian Medical University, Szczecin, Poland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
